BRENTUXIMAB VEDOTIN MAY CUT RADIATION USE IN PEDIATRIC HODGKIN LYMPHOMA

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2021年 / 11卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1318 / 1318
页数：1
相关论文
共 50 条
  • [31] Update on the role of brentuximab vedotin in classical Hodgkin lymphoma
    Tomassetti, Sarah
    Herrera, Alex F.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (09) : 261 - 272
  • [32] Brentuximab Vedotin for Stage III or IV Hodgkin's Lymphoma
    Crump, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (16): : 1559 - +
  • [33] Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
    Salihoglu, A.
    Elverdi, T.
    Karadogan, I.
    Paydas, S.
    Ozdemir, E.
    Erdem, G.
    Karadurmus, N.
    Akyol, G.
    Kaynar, L.
    Yegin, Z. A.
    Sucak, G.
    Ozkocaman, V.
    Topcuoglu, P.
    Ozcan, M.
    Birtas, E.
    Goker, H.
    Baslar, Z.
    Ferhanoglu, B.
    ANNALS OF HEMATOLOGY, 2015, 94 (03) : 415 - 420
  • [34] Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma
    Makita, Shinichi
    Maruyama, Dai
    Tobinai, Kensei
    ONCOTARGETS AND THERAPY, 2020, 13 : 5993 - 6009
  • [35] Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma
    Siddiqi, Tanya
    Thomas, Sandra H.
    Chen, Robert
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2014, 7 : 79 - 85
  • [36] Brentuximab vedotin as consolidation after hematopoietic cell transplant for relapsed Hodgkin lymphoma in pediatric patients
    Flerlage, Jamie E.
    von Buttlar, Xinyu
    Krasin, Matthew
    Triplett, Brandon
    Kaste, Sue C.
    Metzger, Monika L.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (12)
  • [37] Brentuximab Vedotin Plus Bendamustine Is an Effective Salvage Regimen for Pediatric Patients with Relapsed Hodgkin Lymphoma
    Gulati, Nitya
    Boulad, Farid
    Cancio, Maria I.
    Curran, Kevin J.
    Jackson, Carolyn
    Kernan, Nancy
    Kung, Andrew L.
    O'Reilly, Richard
    Prockop, Susan
    Ramaswamy, Kavitha
    Scaradavou, Andromachi
    Spitzer, Barbara
    Shukla, Neerav
    Steinherz, Peter G.
    Forlenza, Christopher
    BLOOD, 2017, 130
  • [38] Increased Rate of Pulmonary Toxicity in Pediatric Patients with Relapsed Hodgkin Lymphoma Receiving Brentuximab Vedotin
    Faulk, Kelly E.
    Sopfe, Jenna
    Pyle, Laura
    Liptzin, Deborah R.
    Liu, Arthur K.
    Franklin, Anna R. K.
    Cost, Carrye R.
    BLOOD, 2017, 130
  • [39] Treatment of relapsed classical Hodgkin lymphoma in the brentuximab vedotin era
    Graf, Solomon A.
    Gopal, Ajay K.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 151 - 157
  • [40] Brentuximab vedotin treatment in patients with relapsed or refractory Hodgkin lymphoma
    Zsuzsa, Molnar
    Imre, Pinczes Laszlo
    Klara, Piukovics
    Ildiko, Istenes
    Krisztina, Wolf
    Zoltan, Csukly
    Arpad, Szomor
    Arpad, Illes
    Zsofia, Miltenyi
    ORVOSI HETILAP, 2017, 158 (41) : 1630 - 1634
12345